720 related articles for article (PubMed ID: 37060495)
21. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
Harper J; Moses MA
EXS; 2006; (96):223-68. PubMed ID: 16383021
[TBL] [Abstract][Full Text] [Related]
22. Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation.
Qian CN; Tan MH; Yang JP; Cao Y
Chin J Cancer; 2016 Jan; 35():10. PubMed ID: 26747273
[TBL] [Abstract][Full Text] [Related]
23. Endothelial Progenitors in the Tumor Microenvironment.
Testa U; Pelosi E; Castelli G
Adv Exp Med Biol; 2020; 1263():85-115. PubMed ID: 32588325
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
25. [Angiogenesis - possibilities, problems and perspectives].
Kurzyk A
Postepy Biochem; 2015; 61(1):25-34. PubMed ID: 26281351
[TBL] [Abstract][Full Text] [Related]
26. Normalization of the vasculature for treatment of cancer and other diseases.
Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
[TBL] [Abstract][Full Text] [Related]
27. Angiogenesis and vasculogenesis in rheumatoid arthritis.
Szekanecz Z; Besenyei T; Szentpétery A; Koch AE
Curr Opin Rheumatol; 2010 May; 22(3):299-306. PubMed ID: 20305562
[TBL] [Abstract][Full Text] [Related]
28. The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization.
Janic B; Arbab AS
ScientificWorldJournal; 2010 Jun; 10():1088-99. PubMed ID: 20563532
[TBL] [Abstract][Full Text] [Related]
29. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
30. B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling: A Complementary Approach To Disrupt Pathological Vessels?
Ehling M; Celus W; Martín-Pérez R; Alba-Rovira R; Willox S; Ponti D; Cid MC; Jones EAV; Di Conza G; Mazzone M
Circ Res; 2020 Aug; 127(6):707-723. PubMed ID: 32527198
[TBL] [Abstract][Full Text] [Related]
31. The modes of angiogenesis: an updated perspective.
Dudley AC; Griffioen AW
Angiogenesis; 2023 Nov; 26(4):477-480. PubMed ID: 37640982
[TBL] [Abstract][Full Text] [Related]
32. [Neoplasms and angiogenesis].
Lewy-Trenda I
Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
[TBL] [Abstract][Full Text] [Related]
33. The role of angiogenesis in solid tumours: an overview.
Makrilia N; Lappa T; Xyla V; Nikolaidis I; Syrigos K
Eur J Intern Med; 2009 Nov; 20(7):663-71. PubMed ID: 19818284
[TBL] [Abstract][Full Text] [Related]
34. Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy.
Elebiyo TC; Rotimi D; Evbuomwan IO; Maimako RF; Iyobhebhe M; Ojo OA; Oluba OM; Adeyemi OS
Cancer Treat Res Commun; 2022; 32():100620. PubMed ID: 35964475
[TBL] [Abstract][Full Text] [Related]
35. Vessel pruning or healing: endothelial metabolism as a novel target?
Cantelmo AR; Pircher A; Kalucka J; Carmeliet P
Expert Opin Ther Targets; 2017 Mar; 21(3):239-247. PubMed ID: 28081641
[TBL] [Abstract][Full Text] [Related]
36. Vessel co-option and resistance to anti-angiogenic therapy.
Kuczynski EA; Reynolds AR
Angiogenesis; 2020 Feb; 23(1):55-74. PubMed ID: 31865479
[TBL] [Abstract][Full Text] [Related]
37. Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.
Plate KH; Scholz A; Dumont DJ
Acta Neuropathol; 2012 Dec; 124(6):763-75. PubMed ID: 23143192
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.
Bikfalvi A; Bicknell R
Trends Pharmacol Sci; 2002 Dec; 23(12):576-82. PubMed ID: 12457776
[TBL] [Abstract][Full Text] [Related]
39. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
[TBL] [Abstract][Full Text] [Related]
40. Angiogenesis and angiogenesis inhibitors in cancer.
Giavazzi R; Taraboletti G
Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
